Detalhe da pesquisa
1.
Personalized therapeutic strategies in HER2-driven gastric cancer.
Gastric Cancer
; 24(4): 897-912, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33755862
2.
Healthy lifestyle promotion in primary schools through the board game Kaledo: a pilot cluster randomized trial.
Eur J Pediatr
; 177(9): 1371-1375, 2018 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-29353440
3.
Optimized EGFR Blockade Strategies in EGFR Addicted Gastroesophageal Adenocarcinomas.
Clin Cancer Res
; 27(11): 3126-3140, 2021 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33542076
4.
Pro-metastatic splicing of Ron proto-oncogene mRNA can be reversed: therapeutic potential of bifunctional oligonucleotides and indole derivatives.
RNA Biol
; 7(4): 495-503, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20864806
5.
Modality-specific naming impairment after traumatic brain injury (TBI).
Brain Inj
; 23(11): 920-9, 2009 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20100129
6.
A Comprehensive PDX Gastric Cancer Collection Captures Cancer Cell-Intrinsic Transcriptional MSI Traits.
Cancer Res
; 79(22): 5884-5896, 2019 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31585941
7.
Downregulating Neuropilin-2 Triggers a Novel Mechanism Enabling EGFR-Dependent Resistance to Oncogene-Targeted Therapies.
Cancer Res
; 78(4): 1058-1068, 2018 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29229599
8.
miR-205 mediates adaptive resistance to MET inhibition via ERRFI1 targeting and raised EGFR signaling.
EMBO Mol Med
; 10(9)2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30021798
9.
Increased Lactate Secretion by Cancer Cells Sustains Non-cell-autonomous Adaptive Resistance to MET and EGFR Targeted Therapies.
Cell Metab
; 28(6): 848-865.e6, 2018 12 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30174307
10.
Rituximab Treatment Prevents Lymphoma Onset in Gastric Cancer Patient-Derived Xenografts.
Neoplasia
; 20(5): 443-455, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29574251
11.
Targeted therapies for gastric cancer: failures and hopes from clinical trials.
Oncotarget
; 8(34): 57654-57669, 2017 Aug 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-28915702
12.
Amplification of the MET receptor drives resistance to anti-EGFR therapies in colorectal cancer.
Cancer Discov
; 3(6): 658-73, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23729478